Acumen
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1210-1220 Washington St Ste 210, Newton,...Phone Number
(617) 344-4190Website
www.acumenpharm.comRevenue
-Stock Symbol
ABOSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Acumen
Acumen Pharmaceuticals is a pharmaceutical manufacturing company focused on developing and producing healthcare products aimed at improving patient well-being. From a third-party perspective, the company is recognized for its emphasis on research, quality standards, and the production of reliable pharmaceutical formulations such as tablets, capsules, and liquid medicines for healthcare providers and distribution partners.Explore more
Acumen Org Chart
SS
President & Pbm Capital Board Member
WG
Chief Operating Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acumen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Acumen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Acumen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Acumen has new funding data
Earning: See what the market has to say on Acumen recently announced quarterly report
Click to see if Acumen had a recent Job posting/layoffs
Check if Acumen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Acumen
Product Launch: Get notified when Acumen launches new products
Recommended Actions
Reach out to Masked Content who joined Acumen as Masked Content
Find 3 more new buyers
Compare Similar Companies to Acumen
Compare insights from companies similar to Acumen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acumen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acumen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acumen.
Acumen financials insights
Gather financial insights about Acumen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$160M
2026
Stock/Share Issuance
$35.8M
Acumen Tech Stack
A closer look at the technologies used by Acumen
Most Recent Scoops
Funding
Funding
Person-Based
Events, Medical Research, Pharmaceuticals
Open Position
Project
reports that using the p-tau217 assay as a screening tool in its Phase 2 ALTITUDE-AD study reduced negative amyloid PET scans from over 60% to 17%, decreasing costs by about 40% and reducing patient burden.
Medical Research, Clinical Operations, Healthcare Technology
Project
Medical Research, Pharmaceuticals
Acumen News & Media
Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Acumen Pharmaceuticals, Inc. (ABOS) Bank of America Global Healthcare Conference 2026 May 14, 2026 11:55 AM EDTCompany ParticipantsDaniel O'Connell - CEO...Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
NEWTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today reported financial results for the first quarter of 2026 and provided a business update.Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
NEWTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference on Thursday, May 14, 2026, at 8:55 a.m. PT/11:55 a.m. ET.Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026
NEWTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report first quarter financial results on Tuesday, May 12, 2026. The Company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and financi
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acumen
Sign Up For FreeTo access detailed company insights
Acumen Pharmaceuticals is a pharmaceutical manufacturing company focused on developing and producing healthcare products aimed at improving patient well-being. From a third-party perspective, the company is recognized for its emphasis on research, quality standards, and the production of reliable pharmaceutical formulations such as tablets, capsule... Read More
